Skip to main content

King’s People

Professor Lars Holmberg

Emeritus staff

Emeritus Professor

Contact details

Biography

Lars Holmberg is Professor Emeritus in Cancer Epidemiology at School of Cancer and Pharmaceutical Sciences, King’s College London and at Medical Faculty, University of Uppsala Sweden. Prof Holmberg was recruited to KCL in 2007 to head up an epidemiology group. In 2011, Prof Holmberg also took up the leadership for a Regional Cancer Center in Uppsala, Sweden jointly with his appointment at KCL. Prof Holmberg holds after his retirement in 2016 grants for breast-, prostate- and urinary bladder cancer research and mentors younger colleagues in cancer epidemiology. Prof Holmberg has published more than 350 original articles and 80 reviews and commentaries.

Latest publications

Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the 'ATRESS' phenomenon
Jurrius, P., Green, T., Garmo, H., Young, M., Cariati, M., Gillett, C., Mera, A., Harries, M., Grigoriadis, A., Pinder, S., Holmberg, L. & Purushotham, A., 1 Apr 2020, In : Breast. 50, p. 39-48 10 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1016/j.breast.2020.01.006
Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: A nationwide cohort study
Plym, A., Clements, M., Voss, M., Holmberg, L., Stattin, P. & Lambe, M., 9 Mar 2020, In : BMJ Open. 10, 3, e032914. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1136/bmjopen-2019-032914
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 28 Feb 2020, In : Frontiers in oncology. 10, 263. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.3389/fonc.2020.00263
Serum immunoglobulin G is associated with decreased risk of pancreatic cancer in the Swedish AMORIS study
Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 14 Feb 2020, (Accepted/In press) In : Frontiers in oncology. Research output: Contribution to journal - Article
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: Results from a large population-based cohort
Wennstig, A. K., Wadsten, C., Garmo, H., Fredriksson, I., Blomqvist, C., Holmberg, L., Nilsson, G. & Sund, M., 22 Jan 2020, In : Breast Cancer Research. 22, 1, 10. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1186/s13058-020-1249-2
Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control study
Valachis, A., Garmo, H., Fredriksson, I., Sund, M., Lagerqvist, B. & Holmberg, L., 1 Jan 2020, (Accepted/In press) In : Breast Journal. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1111/tbj.13759
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
Thomsen, F. B., Westerberg, M., Garmo, H., Robinson, D., Holmberg, L., Ulmert, H. D. & Stattin, P., 1 Jan 2020, In : PLoS ONE. 15, 1, e0228447. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1371/journal.pone.0228460
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study
Beckmann, K., Garmo, H., Lindahl, B., Holmberg, L., Stattin, P., Adolfsson, J., Cruickshank, J. K. & Van Hemelrijck, M., 1 Jan 2020, (Accepted/In press) In : PROSTATE CANCER AND PROSTATIC DISEASES. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1038/s41391-020-0220-8
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 2020, In : Frontiers in oncology. 10, p. 263 Research output: Contribution to journal - Article. DOIs: https://doi.org/10.3389/fonc.2020.00263
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in Prostate Cancer data Base Sweden.
George, G. E., Garmo, H. G., Rudman, S., Holmberg, L. H., Robinson, D., Stattin, P., Adolfsson, J. & Van Hemelrijck, M., 4 Dec 2019, (Accepted/In press) In : Scandinavian Journal of Urology. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1080/21681805.2019.1702093

View all publications